Percutaneous Coronary Intervention in Anticoagulated Patients and Balancing the Risk of Stroke and Bleeding To Interrupt or Not To Interrupt?

被引：1
作者：
Wrigley, Benjamin J. [1 ]
Shantsila, Eduard [1 ]
Lip, Gregory Y. H. [1 ]
机构：
[1] Univ Birmingham, Haemostasis Thrombosis & Vasc Biol Unit, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England
来源：
CHEST | 2010年 / 138卷 / 04期
关键词：
EURO HEART SURVEY; ATRIAL-FIBRILLATION; ORAL ANTICOAGULATION; THERAPY; MANAGEMENT; SAFETY; TRIAL;
D O I：
10.1378/chest.10-0789
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：771 / 774
页数：4
相关论文
共 14 条
[1]  
*CLIN GOV BETH NIH, 2008, MAN PAT ATR FIBR UND
[2]   Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial [J].
Connolly, S. ;
Pogue, J. ;
Hart, R. ;
Pfeffer, M. ;
Hohnloser, S. ;
Chrolavicius, S. ;
Yusuf, S. .
LANCET, 2006, 367 (9526) :1903-1912
[3]   Safety of Uninterrupted Anticoagulation in Patients Requiring Elective Coronary Angiography With or Without Percutaneous Coronary Intervention A Systematic Review and Metaanalysis [J].
Jamula, Erin ;
Lloyd, Nancy S. ;
Schwalm, Jon-David ;
Airaksinen, K. E. Juhani ;
Douketis, James D. .
CHEST, 2010, 138 (04) :840-847
[4]   Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment [J].
Karjalainen, Pasi P. ;
Vikman, Saila ;
Niemela, Matti ;
Porela, Pekka ;
Ylitalo, Antti ;
Vaittinen, Mari-Anne ;
Puurunen, Marja ;
Airaksinen, Tuukka J. ;
Nyman, Kai ;
Vahlberg, Tero ;
Airaksinen, K. E. Juhani .
EUROPEAN HEART JOURNAL, 2008, 29 (08) :1001-1010
[5]   Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden [J].
Lagerqvist, Bo ;
James, Stefan K. ;
Stenestrand, Ulf ;
Lindback, Johan ;
Nilsson, Tage ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (10) :1009-1019
[6]   Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment? [J].
Lahtela, Heli ;
Karjalainen, Pasi P. ;
Niemela, Matti ;
Vikman, Saila ;
Kervinen, Kari ;
Ylitalo, Antti ;
Puurunen, Marja ;
Porela, Pekka ;
Nyman, Kai ;
Hinkka-Yli-Salomaki, Susanna ;
Airaksinen, K. E. Juhani .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (06) :1227-1233
[7]   Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: Simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice [J].
Lip, Gregory Y. H. .
THROMBOSIS AND HAEMOSTASIS, 2010, 103 (04) :683-685
[8]   Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation [J].
Lip, Gregory Y. H. ;
Nieuwlaat, Robby ;
Pisters, Ron ;
Lane, Deirdre A. ;
Crijns, Harry J. G. M. .
CHEST, 2010, 137 (02) :263-272
[9]   Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI] [J].
Lip, Gregory Y. H. ;
Huber, Kurt ;
Andreotti, Felicita ;
Arnesen, Harald ;
Airaksinen, K. Juhani ;
Cuisset, Thomas ;
Kirchhof, Paulus ;
Marin, Francisco .
THROMBOSIS AND HAEMOSTASIS, 2010, 103 (01) :13-28
[10]   Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial [J].
Mega, J. L. ;
Braunwald, E. ;
Mohanavelu, S. ;
Burton, P. ;
Poulter, R. ;
Misselwitz, F. ;
Hricak, V. ;
Barnathan, E. S. ;
Bordes, P. ;
Witkowski, A. ;
Markov, V. ;
Oppenheimer, L. ;
Gibson, C. M. .
LANCET, 2009, 374 (9683) :29-38
12